14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 60 days ( 0 % )
Last Price $0.0001 0 %
High/ Low $0.0001 - $0.0001 0%
Chg 7 Days N/A $0.0001 $0.0001
Chg 30 Days N/A $0.0001 $0.0001
Chg 12 mos -99.98 % $0.461 $0.0001
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos -40.21 % Width: 180.03 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos N/A - $0.148 -100.00 % - 147,674.01 %
Short MA avg 3 mos Sell 0000-00-00 - N/A days
Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short/Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short MA avg 12 mos Sell 2022-12-20 - 82 days
Long MA avg 12 mos Sell 2022-11-23 - 100 days
Short/Long MA avg 12 mos Sell 0000-00-00 - N/A days
Pivot Short Buy 2023-04-18 - 2 days
Bollinger Sell 0000-00-00 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Genocea Biosciences

Genocea Biosciences Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products include GEN-011, an adoptive T cell therapy, which is in Phase 1/2a clinical trials for the treatment of so... GNCA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT